KR20220098049A - 피부 질환 치료에서의 국소적 사용을 위한 니코틴아미드 리보사이드 조성물 - Google Patents

피부 질환 치료에서의 국소적 사용을 위한 니코틴아미드 리보사이드 조성물 Download PDF

Info

Publication number
KR20220098049A
KR20220098049A KR1020227022241A KR20227022241A KR20220098049A KR 20220098049 A KR20220098049 A KR 20220098049A KR 1020227022241 A KR1020227022241 A KR 1020227022241A KR 20227022241 A KR20227022241 A KR 20227022241A KR 20220098049 A KR20220098049 A KR 20220098049A
Authority
KR
South Korea
Prior art keywords
composition
nicotinamide riboside
skin
salt
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1020227022241A
Other languages
English (en)
Korean (ko)
Inventor
앤 데렌-르위스
트로이 로네무스
Original Assignee
크로마덱스 아이엔씨.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 크로마덱스 아이엔씨. filed Critical 크로마덱스 아이엔씨.
Publication of KR20220098049A publication Critical patent/KR20220098049A/ko
Ceased legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/18—Antioxidants, e.g. antiradicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Birds (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Cosmetics (AREA)
KR1020227022241A 2013-10-30 2014-10-30 피부 질환 치료에서의 국소적 사용을 위한 니코틴아미드 리보사이드 조성물 Ceased KR20220098049A (ko)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201361897713P 2013-10-30 2013-10-30
US61/897,713 2013-10-30
PCT/US2014/063260 WO2015066382A1 (en) 2013-10-30 2014-10-30 Nicotinamide riboside compositions for topical use in treating skin conditions
KR1020217026414A KR20210107895A (ko) 2013-10-30 2014-10-30 피부 질환 치료에서의 국소적 사용을 위한 니코틴아미드 리보사이드 조성물

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
KR1020217026414A Division KR20210107895A (ko) 2013-10-30 2014-10-30 피부 질환 치료에서의 국소적 사용을 위한 니코틴아미드 리보사이드 조성물

Publications (1)

Publication Number Publication Date
KR20220098049A true KR20220098049A (ko) 2022-07-08

Family

ID=53005146

Family Applications (3)

Application Number Title Priority Date Filing Date
KR1020227022241A Ceased KR20220098049A (ko) 2013-10-30 2014-10-30 피부 질환 치료에서의 국소적 사용을 위한 니코틴아미드 리보사이드 조성물
KR1020167014302A Ceased KR20160067195A (ko) 2013-10-30 2014-10-30 피부 질환 치료에서의 국소적 사용을 위한 니코틴아미드 리보사이드 조성물
KR1020217026414A Ceased KR20210107895A (ko) 2013-10-30 2014-10-30 피부 질환 치료에서의 국소적 사용을 위한 니코틴아미드 리보사이드 조성물

Family Applications After (2)

Application Number Title Priority Date Filing Date
KR1020167014302A Ceased KR20160067195A (ko) 2013-10-30 2014-10-30 피부 질환 치료에서의 국소적 사용을 위한 니코틴아미드 리보사이드 조성물
KR1020217026414A Ceased KR20210107895A (ko) 2013-10-30 2014-10-30 피부 질환 치료에서의 국소적 사용을 위한 니코틴아미드 리보사이드 조성물

Country Status (12)

Country Link
US (2) US10688118B2 (https=)
EP (1) EP3063163B1 (https=)
JP (1) JP6509844B2 (https=)
KR (3) KR20220098049A (https=)
CN (2) CN105873937A (https=)
AU (1) AU2014342185B2 (https=)
CA (1) CA2928656C (https=)
ES (1) ES2925879T3 (https=)
MX (2) MX394291B (https=)
NZ (1) NZ719328A (https=)
WO (1) WO2015066382A1 (https=)
ZA (1) ZA201603314B (https=)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2017518306A (ja) * 2014-06-02 2017-07-06 グラクソスミスクライン、インテレクチュアル、プロパティー、（ナンバー２）、リミテッドＧｌａｘｏｓｍｉｔｈｋｌｉｎｅ Ｉｎｔｅｌｌｅｃｔｕａｌ Ｐｒｏｐｅｒｔｙ （Ｎｏ．２） Ｌｉｍｉｔｅｄ 結晶性β−Ｄ−ニコチンアミドリボシドの製造および使用
AU2015270090A1 (en) 2014-06-06 2016-12-22 Glaxosmithkline Intellectual Property (No.2) Limited Nicotinamide riboside analogs and pharmaceutical compositions and uses thereof
US10323058B2 (en) 2014-07-24 2019-06-18 W. R. Grace & Co.-Conn. Crystalline form of nicotinamide riboside
EP3268379B1 (en) 2015-03-09 2023-11-01 W.R. Grace & CO. - CONN. Crystalline form of nicotinamide riboside
WO2016149395A1 (en) * 2015-03-16 2016-09-22 ChromaDex Inc. Nicotinic acid riboside or nicotinamide riboside compositions, reduced derivatives thereof, and the use thereof
WO2016178944A1 (en) 2015-05-01 2016-11-10 The Procter & Gamble Company Method of improving the appearance of skin and compositions therefor using nicotinamide riboside
JP2018515485A (ja) 2015-05-01 2018-06-14 ザ プロクター アンド ギャンブル カンパニー 皮膚の外観を改善する方法及びニコチンアミドリボシドを使用したそのための組成物
JP6611099B2 (ja) * 2015-05-01 2019-11-27 ザ プロクター アンド ギャンブル カンパニー 皮膚の健康を改善する方法及びそのための組成物
JP2018517774A (ja) 2015-06-10 2018-07-05 エリジウム・ヘルス・インコーポレイテッド ニコチンアミドリボシドおよびプテロスチルベン組成物ならびに皮膚障害の処置のための方法
WO2016210232A1 (en) * 2015-06-25 2016-12-29 N.V. Perricone Llc Niacinamide mononucleotide formulations for skin aging
WO2017004101A1 (en) 2015-06-29 2017-01-05 The Procter & Gamble Company Skin care compositions comprising particles with nicotinamide riboside and methods of using the same
WO2017004100A1 (en) 2015-06-29 2017-01-05 The Procter & Gamble Company Encapsulated particles comprising nicotinamide riboside
WO2017004102A1 (en) 2015-06-29 2017-01-05 The Procter & Gamble Company Multi-component skin care product comprising nicoinamide riboside in a multi-chambered container
EP3236928B1 (en) 2016-01-11 2020-12-09 The Procter and Gamble Company Method of treating a skin condition and compositions therefor
WO2017161165A1 (en) 2016-03-16 2017-09-21 ChromaDex Inc. B-vitamin and amino acid conjugates of nicotinoyl ribosides and reduced nicotinoyl ribosides, derivatives thereof, and methods of preparation thereof
MX393076B (es) * 2016-04-20 2025-03-24 Chromadex Inc Uso de derivados de ribósido de ácido nicotínico o ribósido de nicotinamida, y derivados reducidos de estos, como precursores que incrementan nad+
EP3500267A4 (en) 2016-08-22 2020-03-18 Elysium Health, Inc. NICOTINAMIDRIBOSIDE AND PTEROSTILLE COMPOSITIONS AND METHOD FOR TREATING NEURODEGENERATIVE DISEASES
EP3538099B1 (en) 2016-11-11 2026-04-22 The Queen's University of Belfast Efficient and scalable syntheses of nicotinoyl ribosides and reduced nicotinoyl ribosides, modified derivatives thereof, phosphorylated analogs thereof, adenylyl dinucleotide conjugates thereof, and novel crystalline forms thereof
JP7136795B2 (ja) 2016-11-29 2022-09-13 ユニバーシティー オブ アイオワ リサーチ ファウンデーション 母体の健康および／または子の健康を向上させるためのｎａｄ前駆体の使用
US11071747B2 (en) 2016-11-29 2021-07-27 University Of Iowa Research Foundation Use of NAD precursors for breast enhancement
US11337908B2 (en) 2016-12-21 2022-05-24 Conopco, Inc. Personal care compositions with cystine
EP3558255B1 (en) 2016-12-21 2021-10-13 Unilever IP Holdings B.V. Topical skin lightening additive and composition with amino acids and nicotinamide compounds
JP7084924B2 (ja) 2016-12-21 2022-06-15 ユニリーバー・アイピー・ホールディングス・ベスローテン・ヴェンノーツハップ 難溶性化合物を含むパーソナルケア組成物
US11260005B2 (en) 2016-12-21 2022-03-01 Conopco, Inc. Personal care compositions with glutathione precursor comprising 4-substituted resorcinols and amino acids
RU2651047C1 (ru) * 2017-05-04 2018-04-18 Общество С Ограниченной Ответственностью "Научно-Технологическая Фармацевтическая Фирма "Полисан" Лекарственная композиция цитопротекторного действия и способ ее получения
WO2018213715A1 (en) * 2017-05-18 2018-11-22 Elysium Health, Inc. Methods and compositions for improving sleep
SG11201912267SA (en) 2017-06-19 2020-01-30 Gangadhara Ganapati Nicotinamide riboside derivatives and their uses
CN110785161B (zh) 2017-06-23 2023-06-20 宝洁公司 用于改善皮肤外观的组合物和方法
WO2019023471A1 (en) * 2017-07-28 2019-01-31 Centers For Age Control, Inc. COMPOSITIONS AND METHODS FOR PREVENTING AND INVERTING THE ASPECTS OF AGING
KR102852384B1 (ko) * 2017-09-14 2025-09-01 메구미 타나카 노화 방지제 및 노화 방지 방법
GB201716391D0 (en) * 2017-10-06 2017-11-22 Xobaderm Ltd Kit for delivery of an active compound into a biological barrier
CN112020363A (zh) 2017-12-22 2020-12-01 益力舒健康公司 烟酰胺核苷氯化物的结晶形式
CN112437657A (zh) 2018-07-03 2021-03-02 宝洁公司 处理皮肤状况的方法
WO2019210607A1 (zh) * 2018-08-17 2019-11-07 邦泰生物工程(深圳)有限公司 一种稳定型烟酰胺核糖组合物及其制备方法
KR102060374B1 (ko) * 2018-12-14 2019-12-30 주식회사 휴메딕스 지방알코올 컨쥬게이션된 니코틴아미드 리보사이드 유도체
WO2020131578A2 (en) 2018-12-17 2020-06-25 Mitopower Llc Nicotinyl riboside compounds and their uses
BR112022000963A2 (pt) 2019-07-19 2022-04-05 Biosynth Ag Método de fabricação de sais de nicotinamida ribofuranosídeo, sais de nicotinamida ribofuranosídeo como tal e usos dos mesmos
CN110638827A (zh) * 2019-10-17 2020-01-03 泓博元生命科技（深圳）有限公司 Nadh及其盐在制备皮肤色素抑制剂中的应用
KR102315139B1 (ko) 2019-12-17 2021-10-20 주식회사 휴메딕스 지방아민 컨쥬게이션된 니코틴아미드 리보사이드 유도체
CN111166760A (zh) * 2019-12-17 2020-05-19 浙江安赛新材料科技有限公司 β-烟酰胺单核苷酸或其前体的组合物及制备方法、应用
CN111184732B (zh) * 2020-03-04 2023-09-08 武汉华纳联合药业有限公司 一种复合组合物制剂及其制备方法和皮肤炎症中的应用
CN111454311B (zh) * 2020-04-03 2021-10-19 深圳市迪克曼科技开发有限公司 烟酰胺核糖的有机酸盐及其组合物与制备方法
WO2021234009A1 (fr) * 2020-05-20 2021-11-25 Nuvamid Sa Compositions cosmetiques anti-age comprenant du nmn
FR3110410A1 (fr) * 2020-05-20 2021-11-26 Nuvamid Sa Compositions cosmétiques anti-âge comprenant de la NMN
US10959933B1 (en) 2020-06-01 2021-03-30 The Procter & Gamble Company Low pH skin care composition and methods of using the same
JP7590462B2 (ja) 2020-06-01 2024-11-26 ザ プロクター アンド ギャンブル カンパニー ビタミンｂ３化合物の皮膚への浸透を改善する方法
CN111632049A (zh) * 2020-06-09 2020-09-08 西北农林科技大学 一种通过综合矫正细胞活性氧簇代谢紊乱以缓解睾丸衰老损伤的复合配方
WO2022047182A1 (en) * 2020-08-28 2022-03-03 University Of Washington High dose nicotinamide adenine dinucleotide (nad) precursor regimens for reduction of inflammation in human patients with preexisting inflammation
EP4029496A1 (en) * 2021-01-18 2022-07-20 Universitat de València Pterostilbene and silibinin for preventing, ameliorating or reducing radiation-induced diseases
JP7761652B2 (ja) * 2021-01-19 2025-10-28 バイオシント アクチェンゲゼルシャフト 塩メタセシスによるニコチンアミドリボフラノシド塩の製造方法、そのトシレート塩の結晶形態及びそのクロリド：ヨージド塩の共結晶化した形態
JP2024517463A (ja) * 2021-05-04 2024-04-22 ソヴィダ ソリューションズ リミテッド ニコチンアミドアデニンジヌクレオチド（ｎａｄ）組成物、それらの製造方法、及びそれらの使用方法
CN114129509B (zh) * 2021-12-03 2023-12-01 药酚享科技(北京)有限公司 一种保湿性nmn亲水凝胶剂及其制备方法
CN116621898A (zh) * 2022-04-13 2023-08-22 深圳市迪克曼科技开发有限公司 烟酰胺核糖的有机酸盐及其结晶形态、制备方法与用途
KR102784901B1 (ko) * 2022-06-23 2025-03-21 제너럴바이오(주) Nr, nmn 및 nad를 함유한 피부 주름 개선용 화장료 조성물

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA200305174B (en) * 2001-02-22 2004-09-23 Unilever Plc Skin composition for reducing skin oils and grease.
US7977049B2 (en) 2002-08-09 2011-07-12 President And Fellows Of Harvard College Methods and compositions for extending the life span and increasing the stress resistance of cells and organisms
JP2007521835A (ja) 2004-02-10 2007-08-09 トラスティーズ・オブ・ダートマウス・カレッジ ニコチンアミドリボシドキナーゼ組成物およびそれらの使用方法
JP2008501343A (ja) 2004-06-04 2008-01-24 ワシントン・ユニバーシティ 神経障害を治療するための方法および組成物
US20060229265A1 (en) 2005-03-30 2006-10-12 Sirtris Pharmaceuticals, Inc. Nicotinamide riboside and analogues thereof
WO2006138418A2 (en) 2005-06-14 2006-12-28 President And Fellows Of Harvard College Improvement of cognitive performance with sirtuin activators
CN101257897A (zh) * 2005-07-07 2008-09-03 西特里斯药业公司 用于治疗或预防肥胖、胰岛素抵抗障碍和线粒体相关障碍的方法和相关组合物
WO2007008548A2 (en) * 2005-07-07 2007-01-18 Sirtris Pharmaceuticals, Inc. Methods and related compositions for treating or preventing obesity, insulin resistance disorders, and mitochondrial-associated disorders
EP3369738B1 (en) * 2005-11-18 2020-05-20 Cornell Research Foundation, Inc. Method for making nicotinoyl ribosides and nicotinamide beta-riboside
ES2439582T3 (es) * 2007-03-12 2014-01-23 Dsm Ip Assets B.V. Composiciones cosméticas
US20090069444A1 (en) 2007-09-07 2009-03-12 The United States Of America, As Represented By Th E Secretary Of Agriculture Method to Ameliorate Oxidative Stress and Improve Working Memory Via Pterostilbene Administration
EP2522355B1 (en) * 2010-01-06 2018-02-21 Kabushiki Kaisha Yakult Honsha Dna damage repair promoter for oral application, and elastase activity inhibitor for oral application

Also Published As

Publication number Publication date
CN105873937A (zh) 2016-08-17
EP3063163A1 (en) 2016-09-07
NZ719328A (en) 2022-04-29
CA2928656A1 (en) 2015-05-07
JP2016538271A (ja) 2016-12-08
CA2928656C (en) 2020-07-28
EP3063163A4 (en) 2017-05-10
CN109985056A (zh) 2019-07-09
US20160250241A1 (en) 2016-09-01
EP3063163B1 (en) 2022-08-10
MX385305B (es) 2025-03-18
ZA201603314B (en) 2017-09-27
WO2015066382A1 (en) 2015-05-07
ES2925879T3 (es) 2022-10-20
KR20210107895A (ko) 2021-09-01
MX394291B (es) 2025-03-24
US20200289536A1 (en) 2020-09-17
US10688118B2 (en) 2020-06-23
AU2014342185B2 (en) 2019-01-03
MX2016005574A (es) 2016-12-09
MX2021009652A (es) 2022-07-26
KR20160067195A (ko) 2016-06-13
US11033568B2 (en) 2021-06-15
JP6509844B2 (ja) 2019-05-08

Similar Documents

Publication Publication Date Title
US11033568B2 (en) Nicotinamide riboside compositions for topical use in treating skin conditions
AU2014342185A1 (en) Nicotinamide riboside compositions for topical use in treating skin conditions
Mir-Palomo et al. Inhibition of skin inflammation by baicalin ultradeformable vesicles
KR101715631B1 (ko) 피부 관리를 위한 조성물 및 방법
RU2654804C2 (ru) Антиоксидантные композиции и способы их применения
JP5570992B2 (ja) 皮膚病又は皮膚病変の治療方法及び組成物
US8911774B2 (en) Topical composition for anti-aging skin treatment using dual DNA repair mechanism and method of use
KR20240009434A (ko) 니코틴아미드 아데닌 디뉴클레오티드 (nad) 조성물, 이의 제조 방법 및 이의 사용 방법
ES2661908T3 (es) Asociación sinérgica de la alanina-glutamina, el ácido hialurónico y un extracto de avena y su utilización en una composición destinada a la cicatrización y la reparación de las lesiones cutáneas
ITMI20111806A1 (it) Composizione per il trattamento delle lesioni cutanee
US10071042B2 (en) External dermatological agent for anti-ageing
US20160354411A1 (en) Olivamine-induced improvement in endothelial cells viability and function
HK40011054A (en) Nicotinamide nucleoside composition for topical use in the treatment of dermatosis
US20180185259A1 (en) Methods of treating hyperpigmentation disorders
US20110274775A1 (en) Extracts of southernwood and topical uses thereof
BR112018011580B1 (pt) Compostos de éster, compostos de amida, composição e uso de pelo menos um composto
KR101326026B1 (ko) 펩타이드 유도체를 함유하는 화장료 조성물
JP2007153863A (ja) 毛髪改善外用剤
JP2015229658A (ja) セラミド合成促進剤
MX2007006059A (es) Composicion de crema desmanchadora de piel.
Octavio Inhibition of skin inflammation by baicalin
BR102016022420A2 (pt) Composição tópica, uso cosmético da composição e composição tópica e dermatológica

Legal Events

Date Code Title Description
A107 Divisional application of patent
PA0104 Divisional application for international application

Comment text: Divisional Application for International Patent

Patent event code: PA01041R01D

Patent event date: 20220629

Application number text: 1020217026414

Filing date: 20210819

PA0201 Request for examination
PG1501 Laying open of application
E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20220801

Patent event code: PE09021S01D

E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20230102

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20220801

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I